News articles about Cardiovascular Systems (NASDAQ:CSII) have trended somewhat positive on Saturday, Alpha One Sentiment reports. The research group, a unit of Accern, ranks the sentiment of media coverage by reviewing more than 20 million news and blog sources. Alpha One ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cardiovascular Systems earned a coverage optimism score of 0.08 on Alpha One’s scale. Alpha One also gave media stories about the medical device company an impact score of 33 out of 100, indicating that recent media coverage is unlikely to have an effect on the company’s share price in the immediate future.
A number of equities analysts have weighed in on CSII shares. Lake Street Capital started coverage on shares of Cardiovascular Systems in a research report on Monday, January 30th. They issued a “buy” rating and a $40.00 price target for the company. Needham & Company LLC upped their price target on shares of Cardiovascular Systems from $27.00 to $32.00 and gave the stock a “buy” rating in a research report on Thursday, January 26th. Zacks Investment Research upgraded shares of Cardiovascular Systems from a “hold” rating to a “buy” rating and set a $31.00 price target for the company in a research report on Tuesday, March 7th. Finally, TheStreet upgraded shares of Cardiovascular Systems from a “d” rating to a “c-” rating in a research report on Thursday, May 4th. Two equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $33.00.
Cardiovascular Systems (NASDAQ:CSII) opened at 31.49 on Friday. The stock’s market cap is $1.03 billion. Cardiovascular Systems has a 12-month low of $15.22 and a 12-month high of $32.54. The stock has a 50 day moving average of $29.90 and a 200 day moving average of $26.91.
Cardiovascular Systems (NASDAQ:CSII) last released its quarterly earnings results on Wednesday, May 3rd. The medical device company reported ($0.05) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.05). Cardiovascular Systems had a negative net margin of 14.74% and a negative return on equity of 15.34%. The firm had revenue of $52.10 million for the quarter, compared to analysts’ expectations of $51.13 million. During the same quarter last year, the company earned ($0.31) EPS. The firm’s revenue for the quarter was up 17.1% compared to the same quarter last year. On average, equities research analysts anticipate that Cardiovascular Systems will post ($0.13) earnings per share for the current fiscal year.
COPYRIGHT VIOLATION WARNING: This story was reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this story on another site, it was stolen and reposted in violation of US & international copyright legislation. The original version of this story can be read at https://sportsperspectives.com/2017/05/20/somewhat-favorable-press-coverage-unlikely-to-affect-cardiovascular-systems-csii-share-price-updated-updated-updated.html.
Cardiovascular Systems Company Profile
Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.
Receive News & Ratings for Cardiovascular Systems Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems Inc and related companies with MarketBeat.com's FREE daily email newsletter.